Skip to content

MEDEXPLORE

Active Private limited companyfounded 2013active for 13 yearsAvenue Bourgys (Henri) 11B, 1410 WaterlooKBO/BCE: BE 0533.823.068

Board

1 director, last change in 2020
Director (not named in the articles)
appointed by deed of 06-10-2020 term without a fixed end
earlier manager, until 06-10-2020
listed in the 2025 annual accounts, filed on 31-08-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 17 : Signatures Tous les actes engageant la société, autres que ceux de gestion journalière, même les actes auxquels un…”
deed of 06-10-2020

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
BOUTROS Antoine
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
  • BOUTROS Antoine
    • Director (not named in the articles), from 22-04-2013 to date
    • Manager, until 06-10-2020

Control

Capital

Contribution
€18,600
Source
2025 annual accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 06-10-2020 (in French)
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Majorité et présence modifications statuts, majorité simple voix représentées”
deed of 06-10-2020 (in French)
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Articles 1025 à 1034 Code Judiciaire”
deed of 06-10-2020 (in French)
Membership ruleThe articles set who can become a member or partner, and on what terms.
“Personnes physiques ayant titre de Docteur en médecine, légalement habilités à exercer art de guérir en Belgique, inscrits au tableau ordre…”
deed of 06-10-2020 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Thursday of June at 20:00
deed of 03-06-2024 (in French)

Capital transactions

Capital over time
  1. 03-06-2024 Converted to unavailable equity
  2. 03-06-2024 Converted to available equity
  3. 06-10-2020 Converted to unavailable equity · €20,460

Next steps